Brief: Abeona Therapeutics Reports Q1 2023 Financial Results
May 11 (Reuters) - Abeona Therapeutics Inc ABEO.O :
* ABEONA THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
* ABEONA THERAPEUTICS INC - REITERATES CASH RUNWAY GUIDANCE
INTO
3Q 2024, BEYOND ANTICIPATED TIMING FOR EB-101 BLA POTENTIAL
APPROVAL
* ABEONA THERAPEUTICS INC- QTRLY LOSS PER SHARE $0.54
Source text for Eikon: ID:nGNX1byzM5
Further company coverage: ABEO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abeona Therapeutics
See all newsBrief: Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Ultragenyx rises after FDA nod for rare disorder drug
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports